Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
{{output}}
Alzheimer's disease (AD) is a heterogeneous neurodegenerative disease, with no standard biomarker(s) to detect or confirm its risk at an early stage. The prevalence of AD increases exponentially worldwide in people of ages over 65 and older. Current improveme... ...
